| | SLO | ENG | Piškotki in zasebnost

Večja pisava | Manjša pisava

Izpis gradiva Pomoč

Naslov:Urokinase plasminogen activator (uPA) and plasminogen activator inhibitor type-1 (PAI-1) in breast cancer : correlation with traditional prognostic factors
Avtorji:ID Lampelj, Maja (Avtor)
ID Arko, Darja (Avtor)
ID Čas-Sikošek, Nina (Avtor)
ID Kavalar, Rajko (Avtor)
ID Ravnik, Maja (Avtor)
ID Jezeršek Novaković, Barbara (Avtor)
ID Dobnik, Sarah (Avtor)
ID Fokter Dovnik, Nina (Avtor)
ID Takač, Iztok (Avtor)
Datoteke:.pdf Radiology_and_Oncology_2015_Lampelj_et_al._Urokinase_plasminogen_activator_(uPA)_and_plasminogen_activator_inhibitor_type-1_(PAI-1)_in_b.pdf (597,75 KB)
MD5: A11826B75B1BE7C69B91DD7D6368EE98
 
URL http://www.degruyter.com/view/j/raon.2015.49.issue-4/raon-2014-0049/raon-2014-0049.xml
 
Jezik:Angleški jezik
Vrsta gradiva:Znanstveno delo
Tipologija:1.01 - Izvirni znanstveni članek
Organizacija:MF - Medicinska fakulteta
Opis:Background: Urokinase plasminogen activator (uPA) and plasminogen activator inhibitor type-1 (PAI-1) play a key role in tumour invasion and metastasis. High levels of both proteolytic enzymes are associated with poor prognosis in breast cancer patients. The purpose of this study was to evaluate the correlation between traditional prognostic factors and uPA and PAI-1 expression in primary tumour of breast cancer patients. Patients and methods: 606 primary breast cancer patients were enrolled in the prospective study in the Department of gynaecological oncology and breast oncology at the University Medical Centre Maribor between the years 2004 and 2010. We evaluated the traditional prognostic factors (age, menopausal status, tumour size, pathohistological type, histologic grade, lymph node status, lymphovascular invasion and hormone receptor status), together with uPA and PAI-1. We used Spearman%s rank correlation, Mann Whitney U test and X2 test for statistical analysis. Results: Our findings indicate a positive correlation between uPA and tumour size (p < 0.001), grade (p < 0.001), histological type (p < 0.001), lymphovascular invasion (p = 0.01) and a negative correlation between uPA and hormone receptor status (p < 0.001). They also indicate a positive correlation between PAI-1 and tumour size (p = 0.004), grade (p < 0.001), pathohistological type (p < 0.001) and negative correlation between PAI-1 and hormone receptor status (p = 0.002). Conclusions: Our study showed a relationship between uPA and PAI-1 and traditional prognostic factors. Their role as prognostic and predictive factors remains to be further evaluated.
Ključne besede:urokinase plasminogen activator, plasminogen activator inhibitor, breast cancer
Status publikacije:Objavljeno
Verzija publikacije:Objavljena publikacija
Leto izida:2015
Št. strani:str. 357-364
Številčenje:Letn. 49, št. 4
PID:20.500.12556/DKUM-59286 Novo okno
ISSN:1318-2099
UDK:618.1-006
COBISS.SI-ID:1979259 Novo okno
DOI:10.2478/raon-2014-0049 Novo okno
ISSN pri članku:1318-2099
NUK URN:URN:SI:UM:DK:NWN4HSHW
Datum objave v DKUM:05.04.2017
Število ogledov:1412
Število prenosov:175
Metapodatki:XML DC-XML DC-RDF
Področja:Ostalo
:
Kopiraj citat
  
Skupna ocena:(0 glasov)
Vaša ocena:Ocenjevanje je dovoljeno samo prijavljenim uporabnikom.
Objavi na:Bookmark and Share



Postavite miškin kazalec na naslov za izpis povzetka. Klik na naslov izpiše podrobnosti ali sproži prenos.

Gradivo je del revije

Naslov:Radiology and oncology
Skrajšan naslov:Radiol. oncol.
Založnik:Slovenian Medical Society - Section of Radiology, Croatian Medical Association - Croatian Society of Radiology
ISSN:1318-2099
COBISS.SI-ID:32649472 Novo okno

Gradivo je financirano iz projekta

Financer:ARRS - Agencija za raziskovalno dejavnost Republike Slovenije
Številka projekta:P3-0321
Naslov:Napovedni dejavniki poteka bolezni in odgovora na zdravljenje pri raku dojk in drugih rakih

Licence

Licenca:CC BY-NC-ND 4.0, Creative Commons Priznanje avtorstva-Nekomercialno-Brez predelav 4.0 Mednarodna
Povezava:http://creativecommons.org/licenses/by-nc-nd/4.0/deed.sl
Opis:Najbolj omejujoča licenca Creative Commons. Uporabniki lahko prenesejo in delijo delo v nekomercialne namene in ga ne smejo uporabiti za nobene druge namene.
Začetek licenciranja:11.05.2016

Sekundarni jezik

Jezik:Slovenski jezik
Ključne besede:rak dojke, urokinaza, aktivator plazminogena, plazminogen


Komentarji

Dodaj komentar

Za komentiranje se morate prijaviti.

Komentarji (0)
0 - 0 / 0
 
Ni komentarjev!

Nazaj
Logotipi partnerjev Univerza v Mariboru Univerza v Ljubljani Univerza na Primorskem Univerza v Novi Gorici